Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of highly active antiretroviral therapy failure with chemokine receptor 5 wild type.

HIV medicine - 1 Jul 2004

Bogner J R, Lutz B, Klein H G, Pollerer C, Troendle U, Goebel F D

Abstract excerpt

OBJECTIVES: Approximately 10% of HIV-infected patients fail to respond properly to highly active antiretroviral therapy (HAART). Among other factors, genetic variants of chemokine receptors have been shown to modify the course and outcome of HIV infection. Our objective was to investigate whether a failure of virological response is associated with polymorphisms of the chemokine receptors or cofactors. METHODS: A...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemokine CXCL12

Share to Chemokines, CXC

Share to Receptors, CCR2

Share to Receptors, CCR5

Share to Receptors, Chemokine

Share to Treatment Failure

Source

Identifiers

PMID: 15236615
DOI: 10.1111/j.1468-1293.2004.00219.x

Genes

CCR5
CCR2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of highly active antiretroviral therapy failure with chemokine receptor 5 wild type.PMID 15236615Read ↗

Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy.Semantic proximity Read ↗

CCR5 genotype and pre-treatment CD4+ T-cell count influence immunological recovery of HIV-positive patients during antiretroviral therapy.Semantic proximity Read ↗

Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.Semantic proximity Read ↗

Frequency of CCR5-Δ32, CCR2-64I and SDF1-3'A alleles in HIV-infected and uninfected patients in Istanbul, Turkey.Semantic proximity Read ↗

Treatment history and baseline viral load, but not viral tropism or CCR-5 genotype, influence prolonged antiviral efficacy of highly active antiretroviral treatment.Semantic proximity Read ↗

Is long-term virological response related to CCR5 Delta32 deletion in HIV-1-infected patients started on highly active antiretroviral therapy?Semantic proximity Read ↗

CCR5 delta32 deletion and response to highly active antiretroviral therapy in HIV-1-infected patients.Semantic proximity Read ↗

Homozygous and heterozygous CCR5-Delta32 genotypes are associated with resistance to HIV infection.Semantic proximity Read ↗

Positive influence of the Delta32CCR5 allele on response to highly active antiretroviral therapy (HAART) in HIV-1 infected patients.Semantic proximity Read ↗

Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient.Semantic proximity Read ↗

Discordant response to antiretroviral therapy: HIV isolation, genotypic mutations, T-cell proliferation and cytokine production.Semantic proximity Read ↗

CCR5Delta32 and promoter polymorphisms are not correlated with initial virological or immunological treatment response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.